An advisory panel to the Food and Drug Administration voted against a similar request from Pfizer in mid-September, but the agency is considered likely to grant the request, perhaps before Thanksgiving.
Tag: BioNTech SE
Pfizer Says Its Vaccine Is Highly Effective in 5- to 11-Year-Olds
The companies reported that a lower dose of the vaccine had a 90.7 percent efficacy rate in preventing symptomatic Covid-19 in a clinical trial.
Israel Moves to Allow Entry to Vaccinated Tourists
The plan to reopen to international tourists for the first time since the pandemic began comes as infections are steadily declining in Israel after a fourth wave.
Israel Moves to Allow Entry to Vaccinated Tourists
The plan to reopen to international tourists for the first time since the pandemic began comes as infections are steadily declining in Israel after a fourth wave.
Canada Settles on a Single ‘Vaccine Passport’ for Travel
The document, already in use in five of the country’s 10 provinces and all three of its territories, will replace a patchwork of programs across Canada.
N.Y.C.’s Vaccine Mandate for Teachers Is Delayed by a Court
The mandate, which affects well over 150,000 people working in the nation’s largest school system, was set to go into effect on Monday at midnight.
Moderna vs. Pfizer: Both Knockouts, but One Seems to Have the Edge
A series of studies found that the Moderna vaccine seemed to be more protective as the months passed than the Pfizer-BioNTech vaccine. Here’s why.
Covid Vaccine Prompts Strong Immune Response in Younger Children, Pfizer Says
Vaccinated kids aged 5 to 11 showed evidence of protection against the virus, the company said. The data must be reviewed by the F.D.A. before children can be inoculated.
Biden Falls Short on U.S. Vaccine ‘Arsenal’ Pledge, Experts Say
Congress appropriated $16 billion to ramp up Covid-19 countermeasures, but a new report found that the Biden administration had spent very little of it on expanding vaccine manufacturing capacity.
Vaccine Effectiveness Against Infection May Wane, C.D.C. Studies Find
Federal health officials said the new data justified a campaign of booster shots. But some scientists disagreed, saying not every American needs another dose.